Your browser doesn't support javascript.
loading
Can EGCG Alleviate Symptoms of Down Syndrome by Altering Proteolytic Activity?
Wyganowska-Swiatkowska, Marzena; Matthews-Kozanecka, Maja; Matthews-Brzozowska, Teresa; Skrzypczak-Jankun, Ewa; Jankun, Jerzy.
Afiliação
  • Wyganowska-Swiatkowska M; Department of Dental Surgery and Periodontology, Poznan University of Medical Sciences, Bukowska 70, 60-812 Poznan, Poland. marzena.wyganowska@periona.pl.
  • Matthews-Kozanecka M; Department of Social Sciences, Poznan University of Medical Sciences, Fredry 10, 61-710 Poznan, Poland. pszczolka-maja@o2.pl.
  • Matthews-Brzozowska T; The Chair and Clinic of Maxillofacial Orthopaedics and Orthodontics, Poznan University of Medical Sciences, Bukowska 70, 60-812 Poznan, Poland. teresamatbrzo@gmail.com.
  • Skrzypczak-Jankun E; Urology Research Center, Department of Urology, The University of Toledo-Health Science Campus, 3000 Arlington Ave, Toledo, OH 43614, USA. Ewa.Skrzypczak-Jankun@utoledo.edu.
  • Jankun J; Urology Research Center, Department of Urology, The University of Toledo-Health Science Campus, 3000 Arlington Ave, Toledo, OH 43614, USA. Jerzy.Jankun@utoledo.edu.
Int J Mol Sci ; 19(1)2018 Jan 15.
Article em En | MEDLINE | ID: mdl-29342922
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Catequina / Síndrome de Down Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Catequina / Síndrome de Down Idioma: En Ano de publicação: 2018 Tipo de documento: Article